BIOPHTA

Paris, France

BIOPHTA has pioneered a novel approach to eye care by creating a cutting-edge pharmaceutical platform that enables continuous drug delivery.

$7.1M raised

Jun 2024

Seed

Top Investors

GO CAPITALElaiaUI InvestissementHTL BiotechnologyUnither Pharmaceuticals

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has BIOPHTA raised?

BIOPHTA has raised $7.1M in total funding. The most recent round was Seed. The last funding was announced in June 2024.

Who are BIOPHTA's investors?

BIOPHTA's investors include GO CAPITAL, Elaia, UI Investissement, HTL Biotechnology, Unither Pharmaceuticals.

Where is BIOPHTA headquartered?

BIOPHTA is headquartered in Paris, France.

What does BIOPHTA do?

BIOPHTA has pioneered a novel approach to eye care by creating a cutting-edge pharmaceutical platform that enables continuous drug delivery.

What stage is BIOPHTA at?

BIOPHTA is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 3, 2024.

MLA

"BIOPHTA — Funding & Investors." VCBacked, June 3, 2024, https://www.vcbacked.co/company/biophta. Accessed June 4, 2026.

APA

VCBacked. (2024). BIOPHTA — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/biophta

Wikipedia (cite web)

{{cite web |title=BIOPHTA — Funding & Investors |url=https://www.vcbacked.co/company/biophta |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 3, 2024.